Chelsea Clinton is Director of CLOVER HEALTH INVESTMENTS, CORP. . Currently has a direct ownership of 541,839 shares of CLOV, which is worth approximately $720,645. The most recent transaction as insider was on Jan 03, 2024, when has been sold 206,185 shares (Class A Common Stock) at a price of $0.97 per share, resulting in proceeds of $199,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 542K
0% 3M change
61.43% 12M change
Total Value Held $720,645

Chelsea Clinton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2024
BUY
Grant, award, or other acquisition
$199,999 $0.97 p/Share
206,185 Added 27.56%
541,839 Class A Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
176,991 Added 34.53%
335,654 Class A Common Stock
Sep 22 2022
BUY
Grant, award, or other acquisition
-
20,271 Added 11.33%
158,663 Class A Common Stock
Sep 22 2022
BUY
Exercise of conversion of derivative security
-
38,392 Added 21.72%
138,392 Class A Common Stock
Mar 03 2022
BUY
Open market or private purchase
$253,000 $2.53 p/Share
100,000 Added 50.0%
100,000 Class A Common Stock

Also insider at

IAC
IAC/InterActiveCorp Communication Services
EXPE
Expedia Group, Inc. Consumer Cyclical
CC

Chelsea Clinton

Director
New York, NY

Track Institutional and Insider Activities on CLOV

Follow CLOVER HEALTH INVESTMENTS, CORP. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLOV shares.

Notify only if

Insider Trading

Get notified when an Clover Health Investments, Corp. insider buys or sells CLOV shares.

Notify only if

News

Receive news related to CLOVER HEALTH INVESTMENTS, CORP.

Track Activities on CLOV